Two Sigma Securities’s IceCure Medical ICCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-743
Closed -$13.6K 1885
2025
Q4
$13.6K Sell
743
-929
-56% -$20.8K ﹤0.01% 1250
2025
Q3
$50.9K Buy
1,672
+827
+98% +$24.7K 0.01% 987
2025
Q2
$25.2K Buy
+845
New +$27.2K ﹤0.01% 1173
2025
Q1
Sell
-567
Closed -$18.7K 1794
2024
Q4
$18.7K Buy
+567
New +$13K ﹤0.01% 1332
2024
Q1
Sell
-552
Closed -$17.7K 3248
2023
Q4
$17.7K Sell
552
-243
-31% -$6.44K ﹤0.01% 2738
2023
Q3
$12.9K Buy
795
+334
+72% +$10.5K ﹤0.01% 2649
2023
Q2
$16K Buy
+461
New +$16.5K ﹤0.01% 2533

Other funds holding ICCM

Two Sigma Securities's ICCM Position: Q1 2026 in Review

Two Sigma Securities sold out of IceCure Medical (ICCM) in Q1 2026, closing a stake of 743 shares — an estimated $13.6K sold.

Two Sigma Securities first reported a position in ICCM in Q2 2023 and held it in 7 quarters. The position peaked at $50.9K in Q3 2025. 17 funds tracked by Wall St. Rank hold ICCM as of Q1 2026.

  • Two Sigma Securities reported no remaining IceCure Medical position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 743 IceCure Medical shares in Q1 2026, an estimated $13.6K.
  • Two Sigma Securities first reported a position in IceCure Medical in Q2 2023 and held it in 7 quarters.
  • Two Sigma Securities's IceCure Medical position peaked at $50.9K in Q3 2025.
  • 17 funds tracked by Wall St. Rank held IceCure Medical as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.